e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

Silvia Navis

Author Profile
2
Publications
1
Years Active
5
Collaborators
50
Citations

Publications by Silvia Navis

2 publications found • Active 2021-2021

2021

2 publications

Pharmacological & Non-Pharmacological Interventions For Stroke Induced Depression: A Review

with Rinu Mary Thomas, Sam Jincy Das, Prasobh GR
5/1/2021

ABSTRACTPost stroke depression (PSD) is a mood disorder in which depression and anhedonia results from stroke. Stroke is a neurological deficit of cerebrovascular cause which persist either beyond 24hrs or is interrupted by death within 24hrs. Depression is a common mental disorder characterized by depressed mood, loss of interest, Feeling of guilt, disturbed sleep, decreased appetite. Development of PSD may result from the mental distress associated with physical disability. There is no reliable and universal treatment for PSD despite its debilitating effects on quality of life in stroke patients. Most of the antidepressant influences the serotoninergic, adrenergic and dopaminergic systems with the aim of accelerating serotonin, dopamine and nor-epinephrine. The different therapeutic approaches to treat PSD include Antidepressants, psychotherapy, surgical therapy, Transcranial magnetic stimulation, acupuncture, music therapy. In this review we are compiling different treatment options available for post stroke depression. Keywords: Post stroke depression, antidepressant, psychotherapy, Transcranial magnetic stimulation, acupuncture, music therapy

Post – Stroke Depression: A Review

with Bincy Ravi, Shahin S, Prasobh GR
4/1/2021

ABSTRACTThe third leading cause of death is stroke, mainly occurred in patients with 50 years or more and it is described as a sudden loss of blood flow to the brain that leads to irreversible tissue damage caused by thrombotic, embolic, or hemorrhagic events. While stroke related psychiatric complications have been recognized for over a century, they have never received the same degree of attention as post stroke motor deficits, language difficulties, or intellectual disturbances. Some of these stroke clinical complications, such as depression and whereas anxiety or emotional liability are other complications. Depression after stroke is associated with a lower quality of life and also with a higher risk of dying. After a stroke, approximately one third of patients experience depression. It’s important to correctly test for and diagnosis post stroke depression, as well as determine the seriousness of the disease. PSD is related to a variety of stroke risk factors and it can be fatal if left untreated. There is good evidence that early initiation of antidepressant treatment is associated with a decreased risk of developing and successful prevention of PSD in non depressed stroke patients. PSD requires special care, and consensus on the diagnosis and treatment of PSD should be achieved. Keywords: Antidepressant, depression, Post stroke depression, Stroke